Get started
Author

Dieudonne J. van der Meer

Observed names: D. Van der Meer, D. van der Meer, Dieudonne van der Meer, Dieudonne van der Meer, Dieudonné J van der Meer, Dieudonné J. van der Meer, Dieudonné van der Meer, Donny van der Meer
ORCID: 0000-0001-9913-7872
Observed ORCID: 0000-0001-9913-7872
OpenAlex ID: A5026393151
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
2019 · Fiona M. Behan, Francesco Iorio, et al. · Nature · 1,331
PDF
Effective drug combinations in breast, colon and pancreatic cancer cells
2022 · Patricia Jaaks, Elizabeth A. Coker, et al. · Nature · 465
Integrated cross-study datasets of genetic dependencies in cancer
2021 · Clare Pacini, Joshua M. Dempster, et al. · Nature Communications · 307
PDF
Cell Model Passports—a hub for clinical, genetic and functional datasets of preclinical cancer models
2018 · Dieudonne van der Meer, Syd Barthorpe, et al. · Nucleic Acids Research · 192
PDF
Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets
2020 · Lisa Dwane, Fiona M Behan, et al. · Nucleic Acids Research · 120
PDF
Simultaneous Analysis of Micro‐ RNA and DNA for Determining the Body Fluid Origin of DNA Profiles,
2013 · Donny van der Meer, Mari L. Uchimoto, et al. · Journal of Forensic Sciences · 72
Differentiating between monozygotic twins through DNA methylation-specific high-resolution melt curve analysis
2015 · Leander Stewart, Neil Evans, et al. · Analytical Biochemistry · 49
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations
2024 · Azadeh C. Bashi, Elizabeth A. Coker, et al. · Cancer Discovery · 42
PDF
A collaborative exercise on DNA methylation based body fluid typing
2016 · Sang‐Eun Jung, Sohee Cho, et al. · Electrophoresis · 32
PDF
Successive bacterial colonisation of pork and its implications for forensic investigations
2017 · Jessica Handke, Noemi Procopio, et al. · Forensic Science International · 16
PDF
Evaluation of Stem-Loop Reverse Transcription and Poly-A Tail Extension in MicroRNA Analysis of Body Fluids
2015 · Hannah Dunnett, Dieudonne van der Meer, et al. · MicroRNA · 11
PDF
Performing body fluid identification with microRNAs using capillary electrophoresis
2015 · Dieudonné J. van der Meer, Graham A. Williams · Forensic science international. Genetics supplement series · 8
PDF
Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer
2025 · Esmee Koedoot, Dieudonné J. van der Meer, et al. · npj Precision Oncology · 7
PDF
Abstract 2803: Ex vivo micro-tumor testing platform to characterize and predict patient-specific immunotherapy drug responses
2026 · Felix M. Behr, Esmee Koedoot, et al. · Cancer Research · 1
Abstract B069: Cell Model Passports—a hub for clinical, genetic and functional datasets of preclinical cancer models
2019 · Dieudonne van der Meer, Syd Barthorpe, et al. · Molecular Cancer Therapeutics · 1
Single Channel Simultaneous Analysis of DNA and MicroRNA
2012 · Mari L. Uchimoto, Dieudonne van der Meer, et al. · University of Huddersfield Repository (University of Huddersfield) · 1
PDF
Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer
2026 · Mathijs P. Scholtes, Esmee Koedoot, et al. · European Urology Open Science
PDF
Abstract 1388: Ex vivo micro-tumor testing platform to guide patient stratification for clinical development of ADCs.
2026 · Esmee Koedoot, Felix M. Behr, et al. · Cancer Research
59 Bispecific antibody ubamatamab elicits patient-specific anti-tumor and immune responses in an ex vivo ovarian cancer platform
2025 · Felix Behr, Esmee Koedoot, et al. · Regular and Young Investigator Award Abstracts
PDF
Abstract A129: Bispecific antibody Ubamatamab induces personalized anti-tumor immune responses in an ex vivo platform for ovarian cancer
2025 · Esmee Koedoot, Felix Behr, et al. · Molecular Cancer Therapeutics
Ex vivo 3D micro-tumor testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer.
2025 · Cornelis de Kroon, Judith R. Kroep, et al. · Journal of Clinical Oncology
PDF
302 (PB290): Ex vivo patient micro tumor testing to characterize and predict immunotherapy drug responses
2024 · E. Koedoot, L. Ceton, et al. · European Journal of Cancer
173 (PB161): Ex vivo 3D micro tumor testing platform to guide patient stratification for clinical development of ADCs
2024 · E. Koedoot, T. Sijsenaar, et al. · European Journal of Cancer
Table S9 from Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations
2024 · Azadeh C. Bashi, Elizabeth A. Coker, et al.
Figure 4 from Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations
2024 · Azadeh C. Bashi, Elizabeth A. Coker, et al.
Works count: 88
Citation count: 2,655
H-index: 11
I10-index: 11
Year
Topic
Type